Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Returns must be shipped to the Netherlands at customer expense per published policy
This safety profile contrasts sharply with full growth hormone, which carries risks of diabetes development, acromegaly (abnormal tissue growth), increased cancer risk, hypertension, and other systemic effects
Avoid other GLP-1 or GIP agonists like semaglutide or tirzepatide alongside Retatrutide due to overlapping mechanisms and compounded side effects
Early demand for oral GLP-1s is likely to come from people already familiar with weight loss treatments, before awareness spreads more widely into the general public
US$ 24.93
US$ 20.04
US$ 22.77
US$ 27.59
US$ 28.90
